Skip to main content

Market Overview

LivaNova: Q4 Earnings Insights

Share:

 

Shares of LivaNova (NASDAQ:LIVN) were unchanged after the company reported Q4 results.

Quarterly Results

Earnings per share fell 29.00% over the past year to $0.71, which beat the estimate of $0.66.

Revenue of $269,600,000 declined by 6.26% year over year, which beat the estimate of $268,830,000.

Outlook

The upcoming fiscal year's EPS expected to be between $1.40 and $1.90.

The upcoming fiscal year's revenue expected to be between $1,009,000,000 and $1,056,000,000.

Details Of The Call

Date: Feb 24, 2021

Time: 08:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/q7xouqfx

Recent Stock Performance

Company's 52-week high was at $77.29

Company's 52-week low was at $33.40

Price action over last quarter: Up 47.16%

Company Overview

U.K.-based LivaNova was born of a combination between Cyberonics in the U.S. and Sorin in Italy. The medical device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. LivaNova derives roughly half of its revenue from the U.S. market, another 21% from Europe, and the remainder from the rest of the world.

 

Related Articles (LIVN)

View Comments and Join the Discussion!

Posted-In: BZI-RecapsEarnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com